{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:42:52Z","timestamp":1785451372673,"version":"3.56.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:00:00Z","timestamp":1725840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-024-03739-z","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:02:42Z","timestamp":1725872562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of oral cyclophosphamide versus mycophenolate mofetil in childhood nephrotic syndrome: an open-label comparative study"],"prefix":"10.1186","volume":"25","author":[{"given":"Gurdeep Singh","family":"Dhooria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet Aulakh","family":"Pooni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,9]]},"reference":[{"issue":"3","key":"3739_CR1","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00467-022-05739-3","volume":"38","author":"A Trautmann","year":"2023","unstructured":"Trautmann A, Boyer O, Hodson E, Bagga A, Gipson DS, Samuel S, et al. International Pediatric Nephrology Association. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 2023;38(3):877\u2013919. https:\/\/doi.org\/10.1007\/s00467-022-05739-3. Epub 2022 Oct 21. PMID: 36269406; PMCID: PMC9589698.","journal-title":"Pediatr Nephrol"},{"key":"3739_CR2","doi-asserted-by":"publisher","unstructured":"Hahn D, Samuel SM, Willis NS, Craig JC, Hobson EM. (2020) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev. 31;2020 CD001533. https:\/\/doi.org\/10.1002\/14651858.CD001533.pub6. PMID: 35659203; PMCID: PMC8094227.","DOI":"10.1002\/14651858.CD001533.pub6"},{"key":"3739_CR3","doi-asserted-by":"publisher","unstructured":"Bagga A, Hari P, Moudgil A, Jordan SC. (2003) Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome. Am J Kidney Dis. 42:1114-20. https:\/\/doi.org\/10.1053\/j.ajkd.2003.08.011. PMID: 14655181.","DOI":"10.1053\/j.ajkd.2003.08.011"},{"key":"3739_CR4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00467-007-0617-9","volume":"22","author":"K Afzal","year":"2007","unstructured":"Afzal K, Bagga A, Menon S, Hari P, Jordan SC. Treatment with mycophenolate mofetil and prednisolone for steroid-dependent nephrotic syndrome. Pediatr Nephrol. 2007;22:2059\u201365. https:\/\/doi.org\/10.1007\/s00467-007-0617-9. Epub 2007 Oct 16. PMID: 17938973.","journal-title":"Pediatr Nephrol"},{"key":"3739_CR5","doi-asserted-by":"publisher","unstructured":"Larkins NG, Liu ID, Willis NS, Craig JC, Hodson EM. Noncorticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children. Cochrane Database Syst Rev. 2020;16. https:\/\/doi.org\/10.1002\/14651858.CD002290.pub5. PMID: 32297308; PMCID: PMC7160055. :4:CD002290.","DOI":"10.1002\/14651858.CD002290.pub5"},{"key":"3739_CR6","doi-asserted-by":"crossref","unstructured":"van Husen M, Kemper MJ. (2011) New therapies in steroid-sensitive and steroid-resistant idiopathic nephrotic syndrome. Pediatr Nephrol. 26:881\u2009\u2013\u200992. Doi: 10.1007\/s00467-010-1717-5. Epub 2011 Jan 13. PMID: 21229269.","DOI":"10.1007\/s00467-010-1717-5"},{"issue":"9","key":"3739_CR7","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1007\/s00467-021-05052-5","volume":"36","author":"J Sandhu","year":"2021","unstructured":"Sandhu J, Bhat D, Dhooria GS, Pooni PA, Bhargava S, Kakkar S, et al. Oral cyclophosphamide therapy in 100 children with steroid-sensitive nephrotic syndrome: experience from a developing country. Pediatr Nephrol. 2021;36(9):2759\u201367. Epub 2021 Mar 31. PMID: 33786660.","journal-title":"Pediatr Nephrol"},{"key":"3739_CR8","unstructured":"Indian Pediatric Nephrology Group, Indian Academy of Pediatrics, Bagga A, Ali U, Banerjee S, Kanitkar M, Phadke KD, Senguttuvan P, Sethi S, Shah M. (2008) Management of steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr 45:203\u2013214."},{"issue":"5","key":"3739_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s13312-021-2217-3","volume":"15","author":"A Sinha","year":"2021","unstructured":"Sinha A, Bagga A, Banerjee S, Mishra K, Mehta A, Agarwal I, et al. Expert Group of Indian Society of Pediatric Nephrology. Steroid sensitive nephrotic syndrome: revised guidelines. Indian Pediatr. 2021;15(5):461\u201381. https:\/\/doi.org\/10.1007\/s13312-021-2217-3.","journal-title":"Indian Pediatr"},{"key":"3739_CR10","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.kint.2018.08.039","volume":"95","author":"A Sinha","year":"2019","unstructured":"Sinha A, Puraswani M, Kalaivani M, Goyal P, Hari P, Bagga A. Efficacy and safety of mycophenolate mofetil versus levamisole in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial. Kidney Int. 2019;95:210\u20138. Epub 2018 Nov 26. PMID: 30497684.","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"3739_CR11","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","volume":"13","author":"S Cuschieri","year":"2019","unstructured":"Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(Suppl 1):S31\u20134. https:\/\/doi.org\/10.4103\/sja.SJA_543_18. PMID: 30930717; PMCID: PMC6398292.","journal-title":"Saudi J Anaesth"},{"key":"3739_CR12","doi-asserted-by":"publisher","unstructured":"Zotta F, Vivarelli M, Emma F. (2022) Update on the treatment of steroid-sensitive nephrotic syndrome. Pediatr Nephrol. 37:303\u2013314. https:\/\/doi.org\/10.1007\/s00467-021-04983-3. Epub 2021 Mar 5. PMID: 33665752.","DOI":"10.1007\/s00467-021-04983-3"},{"issue":"1","key":"3739_CR13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/ndt\/gfq405","volume":"26","author":"B Cammas","year":"2011","unstructured":"Cammas B, Harambat J, Bertholet-Thomas A, Bouissou F, Morin D, Guigonis V, et al. Long-term effects of cyclophosphamide therapy in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome. Nephrol Dial Transpl. 2011;26(1):178\u201384. https:\/\/doi.org\/10.1093\/ndt\/gfq405. Epub 2010 Jul 7. PMID: 20610527.","journal-title":"Nephrol Dial Transpl"},{"key":"3739_CR14","doi-asserted-by":"publisher","unstructured":"Latta K, von Schnakenburg C, Ehrich JH. (2001)A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol. 16(3):271\u2009\u2013\u200982. https:\/\/doi.org\/10.1007\/s004670000523. PMID: 11322378.","DOI":"10.1007\/s004670000523"},{"key":"3739_CR15","doi-asserted-by":"publisher","unstructured":"Querfeld U, Weber LT. (2018) Mycophenolate mofetil for sustained remission in nephrotic syndrome. Pediatr Nephrol. 33(12):2253\u20132265. https:\/\/doi.org\/10.1007\/s00467-018-3970-y. Epub 2018 May 11. PMID: 29750317.","DOI":"10.1007\/s00467-018-3970-y"},{"key":"3739_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, T\u00f6nshoff B, Hoyer P, Querfeld U, Gesellschaft f\u00fcr P\u00e4diatrische Nephrologie (GPN). Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol. 2013;24:1689\u201397. https:\/\/doi.org\/10.1681\/ASN.2012121200. Epub 2013 Jun 27. PMID: 23813218; PMCID: PMC3785276.","journal-title":"J Am Soc Nephrol"},{"key":"3739_CR17","doi-asserted-by":"publisher","unstructured":"Hackl \u00c1, Cseprek\u00e1l O, Gessner M, Liebau MC, Habbig S, Ehren R et al. (2016) Mycophenolate Mofetil Therapy in Children With Idiopathic Nephrotic Syndrome: Does Therapeutic Drug Monitoring Make a Difference? Ther Drug Monit. 38:274-9. https:\/\/doi.org\/10.1097\/FTD.0000000000000258. PMID: 26488204.","DOI":"10.1097\/FTD.0000000000000258"},{"key":"3739_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00467-003-1170-9","volume":"18","author":"U Vester","year":"2003","unstructured":"Vester U, Kranz B, Zimmermann S, Hoyer P. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook. Pediatr Nephrol. 2003;18:661\u20134. https:\/\/doi.org\/10.1007\/s00467-003-1170-9.","journal-title":"Pediatr Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-024-03739-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-024-03739-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T09:03:35Z","timestamp":1725872615000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-024-03739-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,9]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3739"],"URL":"https:\/\/doi.org\/10.1186\/s12882-024-03739-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4241728\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,9]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Ethics Committee Board of Dayanand Medical College and Hospital, Ludhiana, Punjab, India. The study was registered at the Clinical Trials Registry of India (\n                      \n                      ; CTRI\/2021\/06\/034421 [Registered on: 28\/06\/2021]. Written informed consent was obtained from the caretakers of all patients, and assent was obtained for children older than 7 years. Parent information sheet containing background information, safety of the study and possible benefit were provided prior to obtaining consent. The investigators ensured that the subjects\u2019 anonymity is maintained. On the case report forms or other documents, participants will not be identified by their names, but by their assigned identification number.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"296"}}